Starts in 2 months from now
LocationLyngby, Denmark
The Technical University of Denmark (DTU) in collaboration with the Danish Presidency of the Council of the European Union organises a High-Level Conference to explore how academia can attract and retain the brightest minds and shape the future of research in Europe. Are European universities ready to meet the aspirations of early-career researchers?
Bringing together more than 200 people, and attracting the most relevant stakeholders, such as early career researchers, policymakers, university leaders, industry representatives, and other socio-economic actors, the conference will create a space for interactive discussions on the purpose-driven university, working culture, and intersectoral mobility.
Registration will open for onsite and online participation in April 2025. More information about the registration, conference programme, MSCA Falling Walls Lab Pitch competition, testimonials from 10 researchers from Danish universities and practical details is available on the website of the conference.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space AI Continent Defence EDF NATO-EDA
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.